Challenges in recruiting children to a multidrug-resistant TB prevention trial-Reference-Cited by-同舟云学术

Challenges in recruiting children to a multidrug-resistant TB prevention trial

Published:2021-10-01 Issue:10 Volume:25 Page:814-822
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Purchase S.¹,Batist E.¹,Mmile N.²,Nkosi S.³,Workman J.¹,Martinson N.²,Fairlie L.³,Schaaf H. S.⁴,Choo L.⁵,McGowan C.⁵,Crook A. M.⁵,Seddon J. A.⁶,Hesseling A. C.¹

Affiliation:

1. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa

2. Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa

3. Wits Reproductive Health & HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

4. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

5. Institute of Clinical Trials and Methodology, MRC Clinical Trials Unit at University College London, London, UK

6. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa, Department of Infectious Diseases, Imperial College London, Norfolk Place, London, UK

Abstract

BACKGROUND: Recruitment to randomised clinical trials can be challenging and slow recruitment has serious consequences. This study aimed to summarise and reflect on the challenges in enrolling young children to a multidrug-resistant TB (MDR-TB) prevention trial in South Africa.METHODS: Recruitment to the Tuberculosis Child Multidrug-resistant Preventive Therapy Trial (TB-CHAMP) was tracked using an electronic recruiting platform, which was used to generate a recruiting flow diagram. Structured personnel questionnaires, meeting minutes and workshop notes were thematically analysed to elucidate barriers and solutions.RESULT: Of 3,682 (85.3%) adult rifampicin (RIF) resistant index cases with pre-screening outcomes, 1597 (43.4%) reported having no children under 5 years in the household and 562 (15.3%) were RIF-monoresistant. More than nine index cases were pre-screened for each child enrolled. Numerous barriers to recruitment were identified. Thorough recruitment planning, customised tracking data systems, a dedicated recruiting team with strong leadership, adequate resources to recruit across large geographic areas, and excellent relationships with routine TB services emerged as key factors to ensure successful recruitment.CONCLUSION: Recruitment of children into MDR-TB prevention trials can be difficult. Several MDR-TB prevention trials are underway, and lessons learnt from TB-CHAMP will be relevant to these and other TB prevention studies.

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric drug development issues during public health emergencies;Essentials of Translational Pediatric Drug Development;2024

2. Factors associated with screening failure and study withdrawal in multidrug-resistant TB;The International Journal of Tuberculosis and Lung Disease;2022-09-01

3. Improving enrolment for TB preventive treatment;The International Journal of Tuberculosis and Lung Disease;2022-03-01